506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents
Clinical trial NCT00003635 · COMPLETED
Trial details
- NCT number
- NCT00003635
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.